Effectiveness of a Triclosan Containing Toothpaste in Maintaining Periodontal Health in a Type 2 Diabetic Population
The Effect of Periodontal Treatment and the Use of a Triclosan/Copolymer/Fluoride Toothpaste on Glycaemic Control in Diabetics.
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Clinical research study to determine the effectiveness of a triclosan/copolymer/fluoride toothpaste in maintaining periodontal health and therefore glycaemic control in a type 2 diabetic population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Mar 2006
Typical duration for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 26, 2008
CompletedFirst Posted
Study publicly available on registry
September 30, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedResults Posted
Study results publicly available
April 26, 2012
CompletedMarch 3, 2023
April 1, 2012
2.8 years
September 26, 2008
April 2, 2012
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
HbA1c Levels in Blood
Blood is taken from each subject and HbA1c levels were measured at 12 months by Queensland Health Pathology Scientific Services (QHPSS). This test measures the glycated hemoglobin in the blood.
12 months
High Sensitivity CRP (C-Reactive Protein)
CRP is a protein found in the blood and is a marker for inflammation in the body. Inflammation plays a role in the initiation and progression of cardiovascular disease.
12 months
C-Peptide
C-Peptide levels in blood indicate whether or not a person is producing insulin
12 months
IL-6 (Interleukin - 6)
Levels of Interleukin - 6 (GCF IL-6) found in blood drawn from subjects. Indication of systemic inflammation in the body.(weight in picograms)
12 months
TNF-α (Tumor Necrosis Factor - Alpha)
Blood drawn from subjects to determine the level of TNF-α (Tumor necrosis factor - alpha). TNF-α is a pleiotropic inflammatory cytokine involved in systemic inflammation.
12 months
Study Arms (2)
Total toothpaste
ACTIVE COMPARATORBrush whole mouth 2x/day for 12 months with triclosan/copolymer/fluoride toothpaste.
Fluoride mouthrinse
PLACEBO COMPARATORSwish whole mouth 2x/day for 12 months with fluoride mouthrinse.
Interventions
Brush whole mouth 2x/day for 12 months with triclosan/copolymer/fluoride toothpaste. Return for required clinical visits @ 12 months for scaling, root planing and donation samples of dental plaque and blood for microbiological analyses.
Swished around whole mouth twice daily for 12 months. Return for required clinical visits @ 12 months for scaling, root planing and donation samples of dental plaque and blood for microbiological analyses.
Eligibility Criteria
You may qualify if:
- Type 2 diabetes with poor glycaemic control as evidenced by random blood glucose of \>200mg/dl.
- Minimum of 16 teeth
- Chronic periodontitis as indicated by periodontal probing depths \>4mm on at least 6 teeth
You may not qualify if:
- Any condition requiring antibiotic cover for dental treatment
- Other serious illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- William DeVizio, DMD
- Organization
- Colgate Palmolive Co.
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Seymour, BDS, PhD
Otago University
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2008
First Posted
September 30, 2008
Study Start
March 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
March 3, 2023
Results First Posted
April 26, 2012
Record last verified: 2012-04
Data Sharing
- IPD Sharing
- Will not share